Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma

References

• MarisJMRecent advances in neuroblastomaN Engl J Med2010362232202221120558371
   PubMed Web of Science ®Google Scholar
• LaugWESiegelSEShawKNLandingBBaptistaJGutensteinMInitial urinary catecholamine metabolite concentrations and prognosis in neuroblastomaPediatrics19786217783683787
   PubMed Web of Science ®Google Scholar
• ZeltzerPMMarangosPJParmaAMRaised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children’s Cancer Study GroupLancet1983283463613636135871
   PubMed Web of Science ®Google Scholar
• IzbickiTBozekJPerekDWozniakWUrinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children’s neuroblastic tumorsJ Pediatr Surg19912610123012341779334
   PubMed Web of Science ®Google Scholar
• ShusterJJMcWilliamsNBCastleberryRSerum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning studyAm J Clin Oncol19921542953031514525
   PubMed Web of Science ®Google Scholar
• BertholdFHunnemanDHHarmsDKaserHZieschangJSerum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastomaEur J Cancer199228A12195019541419287
   PubMed Web of Science ®Google Scholar
• AydinGBKutlukMTYalcinBVaranAAkyuzCBuyukpamukcuMThe prognostic significance of vanillylmandelic acid in neuroblastomaPediatr Hematol Oncol201027643544820578806
   PubMed Web of Science ®Google Scholar
• SchleiermacherGMichonJRibeiroASegmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)Br J Cancer2011105121940194822146831
   PubMed Web of Science ®Google Scholar
• CocoSTheissenJScaruffiPAge-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaInt J Cancer201213171591160022234802
   PubMed Web of Science ®Google Scholar
• BrodeurGMPritchardJBertholdFRevisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatmentJ Clin Oncol1993118146614778336186
   PubMed Web of Science ®Google Scholar
• HauptRGaraventaAGambiniCImproved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma RegistryJ Clin Oncol201028142331233820351331
   PubMed Web of Science ®Google Scholar
• HunnemanDHMass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 microliter plasmaClin Chim Acta198313521691746652925
   PubMed Web of Science ®Google Scholar
• MonsaingeonMPerelYSimonnetGCorcuffJBComparative values of catecholamines and metabolites for the diagnosis of neuroblastomaEur J Pediatr2003162639740212684897
   PubMed Web of Science ®Google Scholar
• SimonTHeroBHunnemanDHBertholdFTumour markers are poor predictors for relapse or progression in neuroblastomaEur J Cancer200339131899190312932669
   PubMed Web of Science ®Google Scholar
• ViallardJLTigetFHartmannOSerum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomasCancer19886212254625533191453
   PubMed Web of Science ®Google Scholar
• De BernardiBConteMManciniALocalized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for NeuroblastomaJ Clin Oncol19951348848937707115
   PubMed Web of Science ®Google Scholar
• GaraventaABoniLLo PiccoloMSLocalized unresectable neuroblastoma: results of treatment based on clinical prognostic factorsAnn Oncol200213695696412123342
   PubMed Web of Science ®Google Scholar
• De BernardiBCarliMCasaleFStandard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for NeuroblastomaJ Clin Oncol19921012187018781453202
   PubMed Web of Science ®Google Scholar
• De BernardiBMosseriVRubieHTreatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupBr J Cancer20089971027103318766186
   PubMed Web of Science ®Google Scholar
• CaneteAGerrardMRubieHPoor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma ExperienceJ Clin Oncol20092771014101919171715
   PubMed Web of Science ®Google Scholar
• De BernardiBGerrardMBoniLExcellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplificationJ Clin Oncol20092771034104019171711
   PubMed Web of Science ®Google Scholar
• LadensteinRValteau-CouanetDBrockPRandomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyJ Clin Oncol201028213516352420567002
   PubMed Web of Science ®Google Scholar
• GahrMHunnemanDHThe value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in childrenEur J Pediatr198714654894933678274
   PubMed Web of Science ®Google Scholar
• StrengerVKerblRDornbuschHJDiagnostic and prognostic impact of urinary catecholamines in neuroblastoma patientsPediatr Blood Cancer200748550450916732582
   PubMed Web of Science ®Google Scholar
• Di CataldoADauDConteMDiagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for NeuroblastomaMed Science Monit2009151MT1118
   Web of Science ®Google Scholar
• ParodiSPapioFHauptRConteMDe BernardiBThe prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplificationPediatr Blood Cancer2007485593 author reply 593–59416937359
   PubMed Web of Science ®Google Scholar
• NakagawaraAIkedaKHigashiKSasazukiTInverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastomaSurgery1990107143492404349
   PubMed Web of Science ®Google Scholar
• ZambranoEReyes-MugicaMHormonal activity may predict aggressive behavior in neuroblastomaPediatr Dev Pathol20025219019911910515
   PubMed Web of Science ®Google Scholar
• CohnSLPearsonADLondonWBThe International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportJ Clin Oncol200927228929719047291
   PubMed Web of Science ®Google Scholar
• GitlowSEBertaniLMRausenAGribetzDDziedzicSWDiagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urineCancer1970256137713835422912
   PubMed Web of Science ®Google Scholar
• KontrasSBUrinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastomaCancer19621597898614458280
   PubMed Web of Science ®Google Scholar